The Freedland Laboratory focuses on urologic diseases with an emphasis on prostate cancer pathophysiology. Work in the Freedland Lab examines the role of lifestyle in the development and progression of prostate cancer. Information discovered in the Freedland Lab can be used to develop easily implemented lifestyle interventions to prevent premature morbidity and mortality due to urologic diseases. The Freedland Lab also studies causes of racial disparities in prostate cancer and prostate cancer risk stratification.
A bedside-to-bench and back again approach drives our research. Working together with collaborators inside and outside Cedars-Sinai, the Freedland Lab aims ultimately to make a difference in how patients are managed.
The Freedland Laboratory is affiliated with the Cedars-Sinai Cancer Institute, Surgery Department, Division of Urology and the Center for Integrated Research in Cancer and Lifestyle.
Stephen Freedland, MD, is director of the Center for Integrated Research in Cancer and Lifestyle, co-director of the Cancer Genetics and Prevention Program and associate director for faculty development at the Cancer Institute. He is a faculty physician in the Division of Urology at the Cedars-Sinai Surgery Department. Freedland's clinical expertise focuses on urological diseases, particularly benign prostatic hyperplasia and prostate cancer.
Stephen J. Freedland, MD
- Specializes in prostate cancer prevention, management and outcomes
- Increase our knowledge of the interaction between nutritional carbohydrates and prostate cancer.
- The Freedland Lab is also using an in vivo model to look at the effects of cholesterol signaling reduction and restoration on castration-resistant prostate cancer.
Meet Our Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Freedland Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Branche BL, Howard LE, Moreira DM, Roehrborn C, Castro-Santamaria R, Andriole GL, Hopp ML, Freedland SJ.
J Urol. 2018 Feb;199(2):536-542.
Jamnagerwalla J, Howard LE, Allott EH, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, Freeman MR, Freedland SJ.
Prostate Cancer Prostatic Dis. 2017 Dec 27.
Contact the Freedland Lab
8631 W. Third St.
Fourth Floor, Suite 430E
Los Angeles, CA 90048